Capital Advisors Ltd’s Asensus Surgical, Inc. ASXC Stock Holding History

Capital Advisors Ltd’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-551	Closed	–	–	1726
2022 Q3	$0	Hold	551	–	–	﹤0.01%	1594
2022 Q2	$0	Buy	+551	New	+$246	﹤0.01%	1397

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Advisors Ltd's ASXC Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Asensus Surgical, Inc. (ASXC) in Q4 2022, closing a stake of 551 shares.

Capital Advisors Ltd first reported a position in ASXC in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 74 funds tracked by Wall St. Rank hold ASXC as of Q4 2022.

Capital Advisors Ltd reported no remaining Asensus Surgical, Inc. position as of Q4 2022 after selling out during the quarter.
Capital Advisors Ltd sold 551 Asensus Surgical, Inc. shares in Q4 2022.
Capital Advisors Ltd first reported a position in Asensus Surgical, Inc. in Q2 2022 and held it in 2 quarters.
Capital Advisors Ltd's Asensus Surgical, Inc. position peaked at $0 in Q3 2022.
74 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.